David J. Ensz

Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis

Ivan T. Lee, Raffael Nachbagauer, David J. Ensz et al. · Nature Communications · 2023 · 101 citations · Full text

Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results From a Phase 1/2 Randomized Trial

Jintanat Ananworanich, Ivan T. Lee, David J. Ensz et al. · The Journal of Infectious Diseases · 2024 · 41 citations · Full text

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers

Boris Kandinov, Mieke Soens, Wenmei Huang et al. · Human Vaccines & Immunotherapeutics · 2025 · 15 citations · Full text

Risk of COVID-19 after natural infection or vaccination

Anne-Marie Rick, Matthew B. Laurens, Ying Huang et al. · EBioMedicine · 2023 · 13 citations · Full text